scispace - formally typeset
Journal ArticleDOI

Community-acquired pneumonia

S.P. Stone
- 19 Dec 1998 - 
- Vol. 352, Iss: 9145, pp 2019-2019
Reads0
Chats0
About
This article is published in The Lancet.The article was published on 1998-12-19. It has received 1403 citations till now. The article focuses on the topics: Community-acquired pneumonia.

read more

Citations
More filters
Journal ArticleDOI

The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design.

TL;DR: A large, international trial that combines features of adaptive platform trials with pragmatic point-of-care trials to determine best treatment strategies for patients admitted to an intensive care unit with severe community-acquired pneumonia is presented.
Journal ArticleDOI

Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia

TL;DR: Observational analysis of a prospective series of nonimmunosuppressed hospitalized adults with community-acquired pneumonia found discordant therapy is a less frequent cause of failure, which may be preventable by rational application of the current antibiotic guidelines.
Journal ArticleDOI

Pseudomonas aeruginosa: host defence in lung diseases.

TL;DR: P. aeruginosa is ubiquitous in the authors' environment, and one of the most versatile pathogens studied, capable of infecting a number of diverse life forms and surviving harsh environmental factors, but rarely infects healthy human lungs.
Journal ArticleDOI

Community-acquired pneumonia: the annual cost to the National Health Service in the UK

TL;DR: Community-acquired pneumonia in the UK incurs a direct healthcare cost of 440.7 million pounds annually at 1992/1993 prices, and developing and implementing strategies to prevent and minimize hospitalization will significantly reduce this annual cost.
Journal ArticleDOI

Medical Outcomes and Antimicrobial Costs With the Use of the American Thoracic Society Guidelines for Outpatients With Community-Acquired Pneumonia

TL;DR: Findings support the use of erythromycin as recommended by the ATS guidelines for outpatients aged 60 years or younger with no comorbidity, and provide no evidence of improved medical outcomes in the small subgroup who received ATS guideline-recommended therapy.
References
More filters
Journal ArticleDOI

Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago.

TL;DR: Declines with age were found in measures of handicap and life satisfaction, but three quarters of those interviewed reported generally good health and rated their current quality of life as either good or excellent.
Journal ArticleDOI

Causes of death during the first 12 years after spinal cord injury

TL;DR: Though some cause-specific mortality rates for spinal cord injured persons have declined dramatically, many remain substantially above normal and improved methods for preventing and managing these fatal complications must be developed.
Journal Article

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

TL;DR: C. difficile was a common Nosocomial infection on this ward, resulting in asymptomatic carriage more often than diarrhea and accounting for one-fifth of all cases of nosocomial diarrhea.
Journal ArticleDOI

Risk Factors for Clostridium difficile Carriage and C. difficile-Associated Diarrhea in a Cohort of Hospitalized Patients

TL;DR: In this paper, a prospective cohort study of 399 consecutive patients in a single ward over an 11-month period was conducted to identify risk factors for nosocomial C. difficile colonization and diarrhea.
Journal ArticleDOI

Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.

TL;DR: The use of narrow-spectrum antibiotics for hospital treatment of community-acquired infections in the elderly should be encouraged.